Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study-Reference-Cited by-同舟云学术

Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study

Author:

Staerk L.¹^ORCID,Gerds T. A.²,Lip G. Y. H.³⁴,Ozenne B.²,Bonde A. N.¹,Lamberts M.¹,Fosbøl E. L.⁵,Torp-Pedersen C.⁶⁷,Gislason G. H.¹⁸⁹¹⁰,Olesen J. B.¹

Affiliation:

1. Department of Cardiology; Copenhagen University Hospital Herlev and Gentofte; Hellerup Denmark

2. Department of Public Health, Section of Biostatistics; University of Copenhagen; Copenhagen K Denmark

3. Institute of Cardiovascular Sciences; University of Birmingham; Birmingham UK

4. Aalborg Thrombosis Research Unit; Department of Clinical Medicine; Aalborg University; Aalborg Denmark

5. Department of Cardiology; Copenhagen University Hospital Rigshospitalet; Copenhagen Ø Denmark

6. Department of Health, Science and Technology; Aalborg University; Aalborg Denmark

7. Department of Cardiology and Epidemiology/Biostatistics; Aalborg University Hospital; Aalborg Denmark

8. The Danish Heart Foundation; Copenhagen Denmark

9. Faculty of Health and Medical Sciences; University of Copenhagen; Copenhagen N Denmark

10. The National Institute of Public Health; University of Southern Denmark; Copenhagen K Denmark

Funder

Velux Fonden

Publisher

Wiley

Subject

Internal Medicine

Link

Reference36 articles.

3. Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark;Gadsbøll;Eur Heart J,2017

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献